Sun Pharma to buy DUSA

Sun Pharmaceutical Industries, based in India, will acquire DUSA Pharmaceuticals, aiming to advance into the dermatologic market in the United States.

Related Videos
Related Content

The Mainstream Patient: February 7

February 7th 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

The Art of Smelling Good

February 7th 2023

The Cutaneous Connection: An Inside Look of the Inclusive Atlas

November 4th 2021

The Weekly Roundup: January 30-February 3

February 3rd 2023

Losing a Malpractice Case May Depend on Where You Live

February 3rd 2023

The Mainstream Patient: February 7

February 7th 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

The Art of Smelling Good

February 7th 2023

The Cutaneous Connection: An Inside Look of the Inclusive Atlas

November 4th 2021

The Weekly Roundup: January 30-February 3

February 3rd 2023

Losing a Malpractice Case May Depend on Where You Live

February 3rd 2023

The Mainstream Patient: February 7

February 7th 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

The Art of Smelling Good

February 7th 2023

The Cutaneous Connection: An Inside Look of the Inclusive Atlas

November 4th 2021

The Weekly Roundup: January 30-February 3

February 3rd 2023

Losing a Malpractice Case May Depend on Where You Live

February 3rd 2023
Advertise
Contact Us
Job Board
Do Not Sell My Information
Terms and Conditions
Privacy Policy
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.